Drugs / 732462
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01092611 | Mar 2010 → Mar 2014 | AIDS | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 1 | NCT00814762 | Feb 2009 → Aug 2010 | AIDS | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 732462 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01092611 ↗ |
| Known as | F4/AS01B | “received an HIV-1 investigational vaccine (F4/AS01B) or placebo in two previous studies” PMID 29606517 ↗ Mar 2018 |
| Modality | Vaccine | “HIV-1 investigational vaccine (F4/AS01B)” PMID 29606517 ↗ Mar 2018 |